336 related articles for article (PubMed ID: 20017729)
21. The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB
Struik D; Fadda P; Zara T; Zamberletti E; Rubino T; Parolaro D; Fratta W; Fattore L
Pharmacol Res; 2017 Jan; 115():209-217. PubMed ID: 27890818
[TBL] [Abstract][Full Text] [Related]
22. Cannabis: discrimination of "internal bliss"?
Wiley JL
Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
[TBL] [Abstract][Full Text] [Related]
23. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats.
Marco EM; Granstrem O; Moreno E; Llorente R; Adriani W; Laviola G; Viveros MP
Eur J Pharmacol; 2007 Feb; 557(1):37-43. PubMed ID: 17174300
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid tolerance and dependence.
Lichtman AH; Martin BR
Handb Exp Pharmacol; 2005; (168):691-717. PubMed ID: 16596793
[TBL] [Abstract][Full Text] [Related]
25. Modulatory effects of cannabinoids on brain neurotransmission.
Cohen K; Weizman A; Weinstein A
Eur J Neurosci; 2019 Aug; 50(3):2322-2345. PubMed ID: 30882962
[TBL] [Abstract][Full Text] [Related]
26. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
Cooper ZD; Haney M
Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
[TBL] [Abstract][Full Text] [Related]
27. Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking mu-opioid receptors.
Chen RZ; Frassetto A; Fong TM
Brain Res; 2006 Sep; 1108(1):176-8. PubMed ID: 16828068
[TBL] [Abstract][Full Text] [Related]
28. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Braida D; Pozzi M; Cavallini R; Sala M
Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
Covey DP; Wenzel JM; Cheer JF
Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
[TBL] [Abstract][Full Text] [Related]
30. Advances in the field of cannabinoid--opioid cross-talk.
Robledo P; Berrendero F; Ozaita A; Maldonado R
Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
[TBL] [Abstract][Full Text] [Related]
31. Enriched environment and social isolation differentially modulate addiction-related behaviors in male offspring of morphine-addicted dams: The possible role of μ-opioid receptors and ΔFosB in the brain reward pathway.
Yazdanfar N; Farnam A; Sadigh-Eteghad S; Mahmoudi J; Sarkaki A
Brain Res Bull; 2021 May; 170():98-105. PubMed ID: 33592274
[TBL] [Abstract][Full Text] [Related]
32. The endogenous opioid system: a common substrate in drug addiction.
Trigo JM; Martin-García E; Berrendero F; Robledo P; Maldonado R
Drug Alcohol Depend; 2010 May; 108(3):183-94. PubMed ID: 19945803
[TBL] [Abstract][Full Text] [Related]
33. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Morel LJ; Giros B; Daugé V
Neuropsychopharmacology; 2009 Oct; 34(11):2469-76. PubMed ID: 19553915
[TBL] [Abstract][Full Text] [Related]
34. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
Schneider M
Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
[TBL] [Abstract][Full Text] [Related]
35. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
36. Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure.
Maguire DR; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2357-2365. PubMed ID: 29860612
[TBL] [Abstract][Full Text] [Related]
37. Study of cannabinoid dependence in animals.
Maldonado R
Pharmacol Ther; 2002 Aug; 95(2):153-64. PubMed ID: 12182962
[TBL] [Abstract][Full Text] [Related]
38. Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal.
Mohammadkhani A; Borgland SL
J Neurosci Res; 2022 Jan; 100(1):278-296. PubMed ID: 33352618
[TBL] [Abstract][Full Text] [Related]
39. Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.
Maguire DR; France CP
Drug Alcohol Depend; 2020 Jul; 212():108043. PubMed ID: 32497977
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
Spanagel R
Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
